Serum Preptin and Amylin Levels With Respect to Body Mass Index in Polycystic Ovary
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
研究概览
简要总结
Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .
详细描述
Materials and Methods
This is a cross-sectional review of 40 PCOS patients and 40 healthy women who were matched with respect to BMI (<25 kg/m2 and ≥25 kg/m2).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 17 Years 至 35 Years(Child, Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •the patients with PCOS
排除标准
- •Cushing's syndrome 21-hydroxylase deficiency Congenital adrenal hyperplasia Thyroid dysfunction Hyperprolactinemia Diabetes Chronic cardiovascular Hepatic, renal, and hematologic diseases Malignancies Using oral contraceptives, anti-androgens, glucocorticoids, anti-hypertensives, anti-diabetics, calcium supplements and anti-obesity drugs and those who smoke or consume alcohol
结局指标
主要结局
Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
时间窗: six months
Serum Preptin and Amylin Levels will compare between groups
次要结局
未报告次要终点
研究者
Senol Senturk
Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients
Recep Tayyip Erdogan University Training and Research Hospital
